The cell line development market is driven by rising biologics production, increasing demand for monoclonal antibodies, and advancements in expression systems, with North America leading and ...
Machine Learning and Single-Cell Technology Combined to Drive High-Performance Cell Line Development
The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...
Complete the form below to download the infographic. Cell-line development (CLD) is crucial for generating therapeutic ...
Sartorius launched CellCelector CLD, an automated platform combining imaging and cell isolation to accelerate monoclonal cell ...
At Hayward Field, the roar of the crowd is familiar, not just from collegiate competition, but from years of growing up in the stands, watching,... Think about your favorite medicine. Maybe it is a ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...
OneCyte and Kemp Proteins partner to accelerate high-performance cell line development for next-generation biologics: Cambridge, Massachusetts Monday, April 6, 2026, 12:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results